Amebiasis Treatment Market Report Outlines Revenue Share, SWOT Analysis and Supply Chain Outlook, Players - EIN News
Amebiasis Treatment Market
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica
SEATTLE, WASHINGTON, UNITED STATES, January 24, 2022 /EINPresswire.com/ -- New Research Study "Amebiasis Treatment Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/1595
Overview
Amebiasis is a parasitic disease caused by Entamoeba histolytica, which lives in the stool and contaminates food. These cysts release parasites that can cause diarrhea and dysentery. The organism also produces a type of bile that is acidic. Patients with amebiasis may experience these symptoms. The infection usually takes place in the intestine, but there are several treatment options available. The choice of antibiotics depends on the severity of the infection. Anti-parasitic drugs such as amikacin, tetracycline, and rifampin are the most common. A doctor may prescribe a newer drug called diloxanide furoate, or Fungus-S. The treatment will include one or two doses of an antibiotic.
Competitive Landscape
Major companies contributing to the global amebiasis treatment market include Glenmark Pharmaceuticals, Sanofi, Lupin Pharmaceuticals, Inc., Impax Laboratories, Pfizer Inc., Novel Laboratories, Mission Pharmacal Co., Heritage Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd., and Sun Pharmaceutical Industries Inc.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/1595
Drivers
The increasing prescription of antimicrobial drugs such as paromomycin to destroy parasites in patients suffering from intestinal amebiasis is expected to augment the growth of the amebiasis treatment market during the forecast period.
Furthermore, an accelerated pathway for drug approvals by regulatory authorities to boost the commercialization of anti-infection drugs is expected to supplement the growth of the amebiasis treatment market over the forecast period.
Summary of the COVID-19 Aftermath
The COVID-19 prevalence has raised the bar for the global amebiasis treatment market, with a stellar line-up of new drugs from various countries coming together to address the growing cases of infectious diseases. On top of that, the latter-half of the projected timeframe is predicted to show super-sized business prospects for the market participants.
Key Takeaways
The amebiasis treatment market is anticipated to grow at a CAGR of 5.0 % during the forecast period owing to the increasing prevalence of infectious diseases and rising research activities for drug discovery. For instance, in March 2020, a paper published by Elsevier revealed that chloroquine (Aralen), an anti-malaria drug, can be a potential treatment for infectious diseases such as COVID-19 and amebiasis.
Considering the territorial landscape, the North American region is well-positioned to reign supreme in the global amebiasis treatment market at the helm of increasing approval of novel drugs by the U.S. Food and Drug Administration (FDA) to treat infectious diseases.
In the runner-up spot, the Asia Pacific region is viewed as a future ace for the global amebiasis treatment market in the light of improving healthcare facilities, growing government support, and a large patient pool.
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗔𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝗨𝗦𝗗 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/1595
𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other
Comments
Post a Comment